Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Gujarat Kidney and Super Speciality Ltd

NSE: GKSL · BSE: 544666 · Healthcare · 30 announcements

Share price
₹187.12
Market cap
₹1,475 Cr
Revenue (annual)
₹82.01 Cr
Net profit (annual)
₹15.50 Cr
P/E (TTM)
93.2×Sector 53.1×
Promoter holding
71.45%+0.00% QoQ
FII holding
4.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:23 IST BSE
Management Change

Gujarat Kidney and Super Speciality Management Change

Gujarat Kidney and Super Speciality Ltd appointed Mrs. (Dr) Disha Bharpoda as an Additional Non-Executive Independent Director. The Board also noted shareholder approval for IPO proceeds usage.

17:38 IST BSE
Management Change

Gujarat Kidney and Super Speciality Management Change

Gujarat Kidney and Super Speciality Ltd has appointed Mr. Paresh Dhoti as an Additional Non-Executive Independent Director for a five-year term, effective August 14, 2026.

17:22 IST BSE
Management Change

Gujarat Kidney and Super Speciality Management Change

Gujarat Kidney corrected an earlier filing, reclassifying the appointment of Mr. Paresh Dhoti as a Non-Executive Non-Independent Director due to pending IICA registration.

20:24 IST BSE
Management Change

Gujarat Kidney and Super Speciality Management Change

Gujarat Kidney and Super Speciality appointed Mr. Paresh Mohanbhai Dhoti as Independent Director. He joins the board for a five-year term effective July 9, 2026.

Execution
60 months